(Q40198860)

18 September 2017

Identification of a novel EGF-sensitive cell cycle checkpoint (English)

1 reference

18 September 2017

Francesca Walker

1

1 reference

18 September 2017

Hui-Hua Zhang

series ordinal

2

1 reference

18 September 2017

Antony W Burgess

series ordinal

3

1 reference

18 September 2017

language of work or name

English

0 references

publication date

10 November 2006

1 reference

Experimental Cell Research

18 September 2017

1 reference

18 September 2017

313

1 reference

18 September 2017

511-526

1 reference

18 September 2017

3

1 reference

Epidermal growth factor receptor: mechanisms of activation and signalling.

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Untangling the ErbB signalling network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

The ErbB signaling network: receptor heterodimerization in development and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

ErbB receptors: directing key signaling networks throughout life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Biochemical characterization of mutant EGF receptors expressed in the hemopoietic cell line BaF/3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Epidermal growth factor-independent transformation of Ba/F3 cells with cancer-derived epidermal growth factor receptor mutants induces gefitinib-sensitive cell cycle progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Epidermal-growth-factor-dependent activation of the src-family kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Constitutive synthesis of interleukin-3 by leukaemia cell line WEHI-3B is due to retroviral insertion near the gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Reversible G(1) arrest by dimethyl sulfoxide as a new method to synchronize Chinese hamster cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Induction of S phase by G1 regulatory factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Transactivation of the EGF receptor mediates IGF-1-stimulated shc phosphorylation and ERK1/2 activation in COS-7 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Induction of macrophage colony-stimulating factor-dependent growth and differentiation after introduction of the murine c-fms gene into FDC-P1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Progression through G1 and S phases of adult rat hepatocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Growth-factor-dependent mitogenesis requires two distinct phases of signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

The action of epidermal growth factor (EGF) is limited to specific phases of the cell cycle in an EGF dependent colonic cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Tyrosine kinase inhibition: an approach to drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Trafficking of the ErbB receptors and its influence on signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Src promotes destruction of c-Cbl: implications for oncogenic synergy between Src and growth factor receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Multiple positive and negative regulators of signaling by the EGF-receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Identification of a novel inhibitor of mitogen-activated protein kinase kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

ERBB receptor tyrosine kinases and cellular radiation responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Suppressor of cytokine signaling (SOCS)-5 is a potential negative regulator of epidermal growth factor signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Structural alterations of the epidermal growth factor receptor gene in human gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Oncogenic epidermal growth factor receptor mutants with tandem duplication: gene structure and effects on receptor function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

HER2-Mediated Effects on EGFR Endosomal Sorting: Analysis of Biophysical Mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Activated Cdc42 Sequesters c-Cbl and Prevents EGF Receptor Degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

The serine/threonine kinase cyclin G-associated kinase regulates epidermal growth factor receptor signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Mitogen response and cell cycle kinetics of Swiss 3T3 cells in defined medium: differences from human fibroblasts and effects of cell density

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Mechanism in the sequential control of cell morphology and S phase entry by epidermal growth factor involves distinct MEK/ERK activations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

A Restriction Point for Control of Normal Animal Cell Proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

The restriction point and control of cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Anti-sense transforming growth factor alpha oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Targeted inhibition of the epidermal growth factor receptor-tyrosine kinase by ZD1839 ('Iressa') induces cell-cycle arrest and inhibits proliferation in prostate cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Epidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Effects of trastuzumab on epidermal growth factor receptor-dependent and -independent human colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

RNA interference against a glioma-derived allele of EGFR induces blockade at G2M.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Distinct saturable pathways for the endocytosis of different tyrosine motifs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

Enhancement of tumor radioresponse by combined treatment with gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.10.026

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEXCR.2006.10.026

1 reference

18 September 2017

1 reference